surgery• 2025-11-27• Keywords: breast cancer, invasive ductal carcinoma, invasive lobular carcinoma, ductal carcinoma in situ, DCIS, LCIS, paget disease breast, inflammatory breast cancer, triple negative breast cancer, TNBC, HER2 positive breast cancer, ER positive breast cancer, PR positive breast cancer, BRCA1 mutation, BRCA2 mutation, breast cancer screening, mammography, breast MRI, breast ultrasound, breast lump diagnosis, sentinel lymph node biopsy, modified radical mastectomy, breast conserving surgery, neoadjuvant chemotherapy, adjuvant chemotherapy, anthracycline regimen, taxane regimen, tamoxifen therapy, aromatase inhibitors, letrozole, anastrozole, exemestane, trastuzumab, pertuzumab, CDK4/6 inhibitors, palbociclib, bisphosphonates, zoledronic acid, denosumab, metastatic breast cancer, bone metastasis, lung metastasis, liver metastasis, brain metastasis, breast cancer risk factors, breast cancer prevention, prophylactic mastectomy, prophylactic oophorectomy, oncology, neetpg oncology, surgery oncology, pathology breast cancer, radiology breast cancer, TNM staging, breast cancer management, breast cancer mcqs, breast cancer case scenarios, breast cancer notes
